Some pharmacological and biochemical properties of gamma-morpholino-butyrophenone (NSD 2023), a new monoamine oxidase inhibitor.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002090:Butyrophenones / Q000494:pharmacology* / Q000633:toxicity; D006168:Guinea Pigs; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D051379:Mice; D008928:Mitochondria / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology* / Q000633:toxicity; D009025:Morpholines / Q000494:pharmacology* / Q000633:toxicity; D009638:Norepinephrine / Q000378:metabolism; D009928:Organ Specificity; D010847:Picolines / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D011427:Propiophenones / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012701:Serotonin / Q000378:metabolism; D013045:Species Specificity; D014363:Tryptamines / Q000378:metabolism
D000927:Anticonvulsants; D002090:Butyrophenones; D006993:Hypnotics and Sedatives; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D009025:Morpholines; D010847:Picolines; D011427:Propiophenones; D014363:Tryptamines; D012701:Serotonin; D012110:Reserpine; D011335:Proadifen; D009638:Norepinephrine